Dark

Check out our API

BTAI
BioXcel Therapeutics, Inc. Common Stock
stock NASDAQ

At Close

Dec 5, 2025 3:59:52 PM EST

2.08USD-0.478%(-0.01)267,746

0.00Bid 0.00Ask 0.00Spread

Pre-market

Dec 5, 2025 9:24:30 AM EST

2.07USD-0.938%(-0.02)18,175

After-hours

Dec 5, 2025 4:41:30 PM EST

2.07USD-0.481%(-0.01)620

OverviewOptionsHistoricalExchangesShortsTrends

BTAI Reddit Mentions

Subreddits

Limit Labels Price

We have sentiment values and mention counts going back to 2017. The complete data set is available via the API.

Take me to the API

BTAI Specific Mentions

As of Dec 6, 2025 10:06:28 AM EST (<1 min. ago)

Includes all comments and posts. Mentions per user per ticker capped at one per hour.

3 days ago • u/snugulupugus • r/Shortsqueeze • 7645_short_float_on_ibrx_with_bladder_cancer_blas • C

Nah, there are reasons for optimism. First, there's an event on 12/8 that could generate new interest. ["Topics Covered by Drs.Leslie Citrome,Marc Milano, and Leon Ravinto Include Opportunities and Advantages of Self-Administered Treatments at Home"](https://ir.bioxceltherapeutics.com/news-releases/news-release-details/award-winning-journalist-anjalee-khemlani-host-virtual)
Q3 Sales and EPS and GMARG all increased by double QoQ - which doesn't suck. There's a reason why a stock can miss on it's estimated quarterly earnings but not have its share price get pummeled - and that just happened for $BTAI after the 11/12 miss.
Finally, from the 10/14 press release: ["The results, along with the data from the SERENITY At-Home trial, will be included in the supplemental New Drug Application (sNDA) submission that is planned for the first quarter of 2026."](https://ir.bioxceltherapeutics.com/news-releases/news-release-details/bioxcel-therapeutics-announces-positive-results-correlation)
I'm adding small amounts now in expectation of a solid 2026.

3 days ago • u/snugulupugus • r/Shortsqueeze • 7645_short_float_on_ibrx_with_bladder_cancer_blas • C

Nah, there are reasons for optimism. First, there's an event on 12/8 that could generate new interest. ["Topics Covered by Drs.Leslie Citrome,Marc Milano, and Leon Ravinto Include Opportunities and Advantages of Self-Administered Treatments at Home"](https://ir.bioxceltherapeutics.com/news-releases/news-release-details/award-winning-journalist-anjalee-khemlani-host-virtual)
Q3 Sales and EPS and GMARG all increased by double QoQ - which doesn't suck. There's a reason why a stock can miss on it's estimated quarterly earnings but not have its share price get pummeled - and that just happened for $BTAI after the 11/12 miss.
Finally, from the 10/14 press release: ["The results, along with the data from the SERENITY At-Home trial, will be included in the supplemental New Drug Application (sNDA) submission that is planned for the first quarter of 2026."](https://ir.bioxceltherapeutics.com/news-releases/news-release-details/bioxcel-therapeutics-announces-positive-results-correlation)
I'm adding small amounts now in expectation of a solid 2026.

Share